How significant are environmental estrogens to women?

Climacteric

Volumn 1, Issue 3, 1998, Pages 229-242

  Cassidy, A ^a   Milligan, S ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Environmental estrogens; Health; Menopause; Phytoestrogens; Women

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PLANT MEDICINAL PRODUCT;

BREAST TUMOR; CARDIOVASCULAR DISEASE; DIET; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; METABOLISM; PHYSIOLOGY; POLLUTANT; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; DIET; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; ISOFLAVONES; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOESTROGENS; PLANT PREPARATIONS; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 0032167494     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.3109/13697139809085545     Document Type: Article

References (108)

1. Turner KJ, Sharpe RM. Environmental estrogens - present understanding. Rev Reprod 1997;2:69-73
2. Sharpe RM, Skakkebaek NE. Are estrogens involved in falling sperm counts and disorders in the male reproductive tract? Lancet 1993; 341:1392-5
3. Toppari J, Larsen JC, Christiansen C, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996; 104(Suppl 4):741-803
4. Wolff MS, Toniolo PG, Leel EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 1993;85:648-52
5. Cassidy A. Physiological effects of phytooestrogens in relation to cancer and other human health risks. Proc Nutr Soc 1996;55: 399-417
6. Miksicek RJ. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 1993;44:37-43
7. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997;94:14138-43
8. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly oestrogenic. Environ Health Perspect 1995;103:582-7
9. Guillette LJ Jr, Arnold SF, McLachlan JA. Ecosystems and embryos - is there a scientific basis for concern? Anim Reprod Sci 1996;42:13-24
10. Soto AM, Lin TM, Justica H, Silvia RM, Sonnenschein C. An 'in culture' bioassay to assess the estrogenicity of xenobiotics: E-screen. In Colborn T, Clements C, eds. Chemically Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton, NJ: Princeton Scientific Publishing Co., 1992:295-309
11. Routledge EJ, Sumpter JP. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem 1996;15:241-58
12. White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 1994;135:175-82
13. Milligan SR, Balasubramanian AV, Kalita JC. Relative potency of xenobiotic oestrogens in an acute in vivo, mammalian assay. Environ Health Perspect 1998;106:23-6
14. Martin L, Pollard JW, Fagg B. Oestriol, oestradiol 17β and the proliferation and death of uterine cells. J Endocrinol 1976;69: 103-15
15. Kuiper GGJM, Enmark E, Peltohuikki M, Nilsson S, Gustaffson JA. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93: 5925-30
16. Paech K, Webb P, Kuiper GGJM, et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 1997;277: 1508-10
17. Kuiper GGJM, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology 1997;138: 863-70
18. Kuiper GGJM, Nilsson S, Gustaffson JA. Characteristics and function of the novel estrogen receptor β. In O'Malley BW, ed. Hormones and Signalling. New York: Academic Press, 1998;1: 89-112
19. Tetsuka M, Anderson RA, Hillier SG. Distribution of messenger RNA's encoding oestrogen receptor isoforms in female reproductive tissues. J Endocrinol 1997;152(Suppl):OC20
20. Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB. Tissue distribution of estrogen receptors α (ERα) and β (ERβ) mRNA in the midgestational human fetus. J Clin Endocrinol Metab 1997;82:3509-12
21. Cowley SM, Hoare S, Mosselman S, Parker MG. Estrogen receptors α and β form heterodimers on DNA. J Biol Chem 1997;272: 19858-62
22. Safe S, Krishnan V. Chlorinated hydrocarbons: estrogens and antiestrogens. Toxicol Lett 1995; 82:731-6
23. Krishnan V, Porter W, Santostefano M, Wang X, Safe S. Molecular mechanism of inhibition of estrogen induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF7 cells. Mol Cell Biol 1995;15: 6710-19
24. Tran DQ, Klotz DM, Ladlie BL, Ide CF, McLachlan JA, Arnold SF. Inhibition of progesterone receptor activity in yeast by synthetic chemicals. Biochem Biophys Res Commun 1996;229:518-23
25. Leblanc GA, Bain LJ, Wilson VS. Pesticides: multiple mechanisms of demasculinization. Mol Cell Endocrinol 1997;126:1-5
26. Milligan SR, Khan O, Nash M. Competitive binding of xenobiotic oestrogens to rat α feto-protein and to sex steroid binding proteins in human and rainbow trout (Oncorhynchus mykiss) plasma. Gen Comp Endocrin 1998; in press
27. Wang C, Makela T, Hase T, Adlercreutz H, Kurzer M. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem 1994;50:205-12
28. Evans BAJ, Griffiths K, Morton MS. Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995;147:295-302
29. Makela S, Poutanen M, Lehtimaki J, Kostian ML, Santti R, Vihko R. Estrogen-specific 17β-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med 1995; 208:51-9
30. Pathak D, Pathak K, Singla AK. Flavonoids as medicinal agents - recent advances. Fitoterapia 1991;62:371-89
31. Schubert W, Eriksson U, Edgar B, Cullberg G, Hedner T. Flavonoids in grapefruit juice inhibit the in vitro metabolism of 17β-oestradiol. Eur J Drug Metab Pharmacokinetics 1995;20: 219-24
32. Divi RL, Doerge DR. Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol 1996;9:16-23
33. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O. Resveratrol, a remarkable inhibitor of rebonucleotide reductase. FEBS Lett 1998;421:277-9
34. Belguendouz L, Fremont L, Gozzelino MT. Interaction of transresveratrol with plasma lipoproteins. Biochem Pharmacol 1998;55: 811-16
35. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993;342:1209-10
36. Wang TTY, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996; 17:271-5
37. McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci USA 1996;93:10069-73
38. Setchell KDR, Adlercreutz H. Mammalian lignans and phyto-oestrogens. Recent studies on their formation, metabolism and biological role in health and disease. In Rowland IR, ed. Role of the Gut Flora in Toxicity and Cancer. London: Academic Press, 1988: 315-45
39. Ruh MF, Zacharewsi T, Connor K, Howell J, Chen I, Safe S. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem Pharmacol 1995;50:1485-93
40. Arnold SF, Klotz DM, Vonier PM, Collins BM, Guillette LJ Jr, McLachlan JA. Synergistic activation of human estrogen receptor by combinations of environmental chemicals. Science 1996; 272:1489-92
41. Ramamoorthy K, Wang F, Chen IC, et al. Potency of combined estrogenic pesticides [Letter]. Science 1997;275:405-6
42. Ashby J, Lefevre PA, Odum J, Harris CA, Routledge EJ, Sumpter JP. Synergy between synthetic estrogens? Nature (London) 1997; 485:494
43. McLachlan JA. Synergistic effect of environmental estrogens: report withdrawn. Science 1997;277:459
44. Setchell KDR. Overview of isoflavone structure, metabolism and pharmacokinetics. Am J Clin Nutr 1998; in press
45. Safe SH. Environmental and dietary estrogens and human health: is there a problem? Environ Health Persp 1995;103:346-51
46. Jones AE, Price KR, Fenwick GR. Development and application of a HPLC method for the analysis of phytoestrogens. J Sci Food Agr 1989; 46:357-64
47. Nagata C, Takatsuka N, Kurisu Y, Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 1998; 128:209-13
48. Thompson LU, Robb P, Serraino M, Cheug F. Mammalian lignan production from various foods. Nutr Cancer 1991;16:43-52
49. Adlercreutz H, Fotsis T, Bannwart C, et al. Determination of urinary lignans and phytoestrogen metabolites, potential antioestrogens and anticarcinogens, in the urine of women on various habitual diets. J Steroid Biochem 1986; 25:791-7
50. Cassidy A. Plant oestrogens and their relation to hormonal status in women. PhD thesis, Cambridge University, 1991
51. Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones present in soy in premenopausal women: implications for the prevention of breast cancer. Am J Clin Nutr 1994;60: 333-40
52. Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones in young women - importance of the chemical composition of soya products. Br J Nutr 1995;74:587-601
53. Xu X, Wang HJ, Murphy PA, Cook L, Henrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994;124:825-32
54. Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Non-steroidal oestrogens of dietary origin: possible roles in hormone dependent disease. Am J Clin Nutr 1984;40:569-78
55. Sharman M, Read WA, Castle L, Gilbert J. Levels of di-(2-ethylhexyl)phthalate and total phthalate esters in milk, cream, butter and cheese. Food Add Contam 1994;11:375-85
56. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. Xenooestrogens released from lacquer coatings in food cans. Environ Health Perspect 1995;103:608-12
57. Olea N, Pulgar R, Perez P, et al. Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect 1996;104: 298-305
58. Nimrod AC, Benson WH. Environmental estrogenic effects of alkylphenol ethoxylates. Crit Rev Toxicol 1996;26:335-64
59. Lewis SK, Lech JJ. Uptake, disposition, and persistence of nonylphenol from water in rainbow trout (Oncorhynchus mykiss). Xenobiotica 1996;26:813-19
60. Dewailly E, Ayotte P, Bruneau S, Laliberte C, Muir DCG, Norstrom RJ. Inuit exposure to organochlorines through the aquatic food chain in Arctic Quebec. Environ Health Perspect 1993;101:618-20
61. O'Malley M. Clinical evaluation of pesticide exposure and poisonings. Lancet 1997;349: 1161-6
62. Cooper RI, Kavlok RJ. Endocrine disrupters and reproductive development: a weight-of-evidence overview. J Endocrinol 1997;152: 159-66
63. Jacobs DM, Tang MX, Stern Y, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 1998;50:368-73
64. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348: 429-32
65. Lu LJW, Anderson KE, Grady JJ, Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women - implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prevention 1996;5:63-70
66. Cassidy A, Faughnan M, Hughes R, et al. Endocrine-modifying effects of phytoestrogens in postmenopausal women and elderly men. Am J Clin Nutr 1998; in press
67. Wilcox G, Wahlqvist ML, Burger HG, Medley G. Oestrogen effects of plant derived foods in postmenopausal women. Br Med J 1990;301: 905-6
68. Gavaler JS, Van Thiel DH, Galvao-Teles A. Oestrogenic responses in normal postmenopausal women to administration of the phytoestrogens in bourbon whiskey. Hepatology 1991;14:87
69. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80: 1685-90
70. Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes - effect of soy and wheat. Maturitas 1995;21:189-95
71. Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4: 89-94
72. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio P. The effect of dietary soya supplementation on hot flushes. Obstet Gynecol 1998;91:6-11
73. Sturdee DW. Clinical symptoms of oestrogen deficiency. Curr Obstet Gynaecol 1997;7: 190-6
74. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325: 756-62
75. Sarrel PM. Ovarian hormones and the circulation. Maturitas 1990;12:287-98
76. O'Brien T, Nguyen TT. Lipids and lipoproteins in women. Mayo Clin Proc 1997;72:235-44
77. Sirtori CR, Even R, Lovati MR. Soyabean diet and plasma cholesterol: from therapy to molecular mechanisms. Ann NY Acad Sci 1993;676: 188-201
78. Arjmandi BH, Khan DA, Juma SS, Svanborg A. The ovarian hormone deficiency induced hypercholesterolemia is reversed by soy protein and the synthetic isoflavone, ipriflavone. Nutr Res 1997;17:885-94
79. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peri-pubertal rhesus monkeys. J Nutr 1996;126: 43-50
80. Magness RR, Rosenfield CR. Local and systemic oestradiol 17β: effects on uterine and systemic vasodilation. Am J Physiol 1989;256: E536-42
81. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996;10:615-24
82. Honore EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 1997;67:148-54
83. Fotsis T, Peper M, Adlercreutz H, et al. Genistein, a dietary derived inhibitor of angiogenesis. Proc Natl Acad Sci, USA 1993;90: 2690-4
84. Jaggers DC, Collins WP, Milligan SR. Potent inhibitory effects of steroids in an in vitro model of angiogenesis. J Endocrinol 1996;150:457-64
85. 2+ entry in human platelets. FEBS Lett 1993;315:242-6
86. Wilcox JN, Blumenthal BF. Thrombotic mechanisms in atherosclerosis: potential impact of soy protein. J Nutr 1995;125:631s-8s
87. Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA. Antioxidant activity of phytoestrogenic isoflavones. Free Rad Res 1997;26:63-70
88. Tobias JH, Cook DG, Chambers TJ, Dalzell N. A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women. Clin Sci 1994;87:587-91
89. Ho SC. Body measurements, bone mass and fractures - does the Easter differ from the West? Clin Orthop 1996;323:75-80
90. Kao PC, P'eng FK. How to reduce the risk factors of osteoporosis in Asia. Chung Hua I Hsueh Tsa Chih Taipei 1995;55:209-13
91. Anderson JJ, Ambrose WW, Garner SC. Orally dosed genistein from soy and prevention of cancellous bone loss in two ovarectomised rat models [Abstract]. J Nutr 1995;125:799s
92. Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovarectomised rat model of osteoporosis. J Nutr 1996;126:161-7
93. Tsutsumi N, Kawashima K, Nagata H, Ujiie A, Endo H. Effects of KCA-012 on bone metabolism in organ culture. Jpn J Pharmacol 1995;67: 169-71
94. Yoshida K, Tsukamoto T, Torii H, et al. Metabolism of ipriflavone TC-80; in rats. Radioisotopes 1985;34:612-17
95. Cheng SL, Zhang SF, Nelson TL, Warlow PM, Civitelli R. Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites. Calcif Tissue Int 1994;55: 356-62
96. Brandi ML. New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs. Am J Med 1993;95(suppl 5A): 69S-74S
97. Melis GB, Paoletti AM, Bartolini R, et al. Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium. Bone Miner 1992;19(Suppl 1): S49-56
98. Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction in bone loss in ovarectomised rats. J Cell Biochem 1996; 61:630-7
99. Manolagas SC, Jilka R. Bone marrow, cytokines and bone remodelling. N Engl J Med 1995;332:305-11
100. Erdman JW, Stillman RJ, Lee KF. Short-term effects of soybean isoflavones on bone in postmenopausal women. Am J Clin Nutr 1998; in press
101. Pansini F, Bonaccorsi G, Albertazzi P, et al. Soy phytoestrogens and bone. Presented at the Proceedings of North American Menopause Society, 1997;abstr 44
102. Colerangle JB, Roy D. Exposure of environmen-tal estrogenic compound nonylphenol to Nobel rat alters cell cycle kinetics in the mammary gland. Endocrine 1996;4:115-22
103. Hunter DJ, Hankinson SE, Laden F, et al. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 1997;337:1253-8
104. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997;350:990-4
105. Petrakis NL, Barnes S, King EB, et al. Stimulatory influence of soy protein isolate on breast secretion in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prevention 1996;5:785-94
106. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk? Cancer 1985;56:1206-8
107. Ferguson DJP, Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. Br J Cancer 1981;44:177-81
108. Anderson TJ, Ferguson DJP, Raab GM. Cell turnover in the 'resting' human breast: influence of parity, contraceptive pill, age and laterality. Br J Cancer 1982;46:376-82